Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort

22 Jul 2014

Abstract excerpt

BACKGROUND: The aim of the present study was to analyse the prognostic value of microRNA-21 (miRNA-21) in patients with stage II colon cancer aiming at a risk index for this group of patients. METHODS: A population-based cohort of 554 patients was included. MicroRNA-21 was analysed by qPCR based on tumour tissue. An index was created using the coefficients obtained from a collective multiple Cox regression. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Surgical Treatments
Share to Genetic factors in colorectal cancer
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25051407
DOI: 10.1038/bjc.2014.409

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohortPMID 25051407Read ↗

Diagnostic, prognostic, and therapeutic potency of microRNA 21 in the pathogenesis of colon cancer, current status and prospectiveSemantic proximity Read ↗

Evaulation of miRNAs as a Non-invasive Blood-Based Marker for Detection of Colorectal CancerSemantic proximity Read ↗

12-Gene Recurrence Score Assay Stratifies the Recurrence Risk in Stage II/III Colon Cancer With Surgery Alone: The SUNRISE Study.Semantic proximity Read ↗

Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinomaSemantic proximity Read ↗

Serum miR-21 and miR-210 as promising non-invasive biomarkers for the diagnosis and prognosis of colorectal cancerSemantic proximity Read ↗

Evaluating the Benefits of Tegafur-Uracil Adjuvant Therapy in Low-Risk Stage IIa Colon Cancer: Insights from a Decade-Long StudySemantic proximity Read ↗

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysisSemantic proximity Read ↗

Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal CancerSemantic proximity Read ↗

Combining Senescence-related lncRNA and Bulk-RNA Transcriptome Sequencing to Construct a Prognostic Model and Identify TSPEAR−AS2 as a Potential Therapeutic Target for Colon Adenocarcinoma PatientsSemantic proximity Read ↗

Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinomaSemantic proximity Read ↗

Risks of Subsequent Primary Extracolonic Cancers for Colorectal Cancer Survivors: A Study Protocol for the Development and Validation of a Risk Prediction ModelSemantic proximity Read ↗

Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.